Tag: Medical Equipment and Devices

Displaying 1 - 20 of 23 results.

Pages

Filtering by content type: Press Release

The Federal Trade Commission issued a statement on its vote to close the investigation of the proposed merger of European eyewear makers Essilor and Luxottica Group.According to the statement, the evidence did not support a conclusion that Essilor’s proposed acquisition of Luxottica violates...
The Federal Trade Commission filed a complaint against the nation’s three largest dental supply companies alleging that they violated U.S. antitrust laws by conspiring to refuse to provide discounts to or otherwise serve buying groups representing dental practitioners.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that medical technology company Becton, Dickinson’s proposed $24 billion acquisition of competitor C. R. Bard would violate federal antitrust law by harming competition in two U.S.
Becton, Dickinson and Company and C. R. Bard, Inc. have agreed to divest two medical device product lines to settle Federal Trade Commission charges that Becton, Dickinson’s proposed $24 billion acquisition of Bard would negatively impact competition in those markets. Both companies supply a range...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Integra LifeSciences Holdings Corp.’s $1 billion acquisition of Johnson & Johnson’s Codman Neuro division would negatively impact competition in those markets. Both companies supply...
Following a public comment period, the Federal Trade Commission has approved a final order designed to remedy the anticompetitive effects resulting from Abbott’s $8.3 billion acquisition of Alere.
Abbott Laboratories and Alere Inc. have agreed to a divestiture of two point-of-care medical device products line in order to settle Federal Trade Commission charges that Abbott’s proposed $8.3 billion acquisition of Alere will cause harm to competition.Abbott is a global healthcare company that...
Integra LifeSciences Holdings Corp. and Johnson & Johnson have agreed to a divestiture of five neurosurgical medical device product lines to settle Federal Trade Commission charges that Integra’s proposed $1 billion acquisition of Johnson & Johnson’s Codman Neuro division would negatively...
The Federal Trade Commission will host a workshop tomorrow in Washington, DC, to explore competition, innovation, and consumer protection issues raised by hearing health services and technology.The event is free and open to the public. It will be available via live webcast and live tweeted via...
The Federal Trade Commission has announced a final agenda for the Now Hear This: Competition, Innovation, and Consumer Protection Issues in Hearing Health Care workshop. The event will explore competition, innovation, and consumer protection issues raised by hearing health services and technology. 
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Abbott Laboratories’ $25 billion acquisition of St. Jude Medical, Inc. would likely be anticompetitive.
Global medical technology company Medtronic, Inc. has agreed to divest the drug-coated balloon catheter business of Ireland-based medical products company Covidien plc, in order to settle Federal Trade Commission charges that its $42.9 billion acquisition of Covidien would likely be anticompetitive...
At the Federal Trade Commission’s request, a U.S. district court has temporarily shut down a Brooklyn, New York-based operation that the allegedly used deception, threats, and intimidation to induce elderly consumers to pay for medical alert systems they neither ordered nor wanted.
Following a public comment period, the Federal Trade Commission has approved a final settlement order in the matter of Danaher Corporation and MDS, Inc., and sent a letter to the one member of the public who commented on it. The final order settles charges that Danaher’s acquisition of MDS, as...
The Federal Trade Commission announced today that it will require the divestiture of MDS Inc.’s assets related to its laser microdissection business as a condition of allowing Danaher Corporation and MDS Analytical Technologies (US) Inc. to proceed with their proposed merger. The proposed...
Following the Federal Trade Commission’s approval of a lawsuit to block the transaction, Thoratec Corporation today announced that it has abandoned its proposed $282 million acquisition of HeartWare International. The FTC’s complaint charged that the deal would be illegal because it would...
The Federal Trade Commission has authorized a lawsuit to block Thoratec Corporation’s proposed $282 million acquisition of rival medical device maker HeartWare International, Inc., charging that the transaction would substantially reduce competition in the U.S. market for left ventricular devices (...
Getinge AB has settled Federal Trade Commission charges that its proposed $865 million acquisition of rival Datascope Corporation would be anticompetitive and would violate federal antitrust laws. Under the settlement with the Commission, Datascope is required to divest its endoscopic vessel...
Commission issuance of information requests: The Commission has issued information requests to generic and authorized generic drug manufacturers and marketers as part of its ongoing study of the short- and long-term effects of authorized generics on pharmaceutical drug competition. The current set...
The Federal Trade Commission today announced a complaint challenging Kyphon, Inc.’s (Kyphon) proposed acquisition of the spinal assets of Disc-O-Tech Medical Technologies, Ltd. and Discotech Orthopedic Technologies, Inc. (collectively Disc-O-Tech) as anticompetitive in the U.S. market for minimally...

Pages